Doctors Hospital Announces Partnership with Cizzle Bio to Bring Innovative Cancer Detection Tests to the Cayman Islands

Doctors Hospital is proud to announce a new partnership with Cizzle Bio, a biotechnology company developing advanced biomarker blood tests for the early detection of lung and gastric cancers. Through this collaboration, Doctors Hospital plans to introduce Cizzle Bio’s CIZ1B lung cancer test and DEX-G2 gastric cancer test to its clinical diagnostic services in the near future.

These groundbreaking tests are designed to support earlier, more accurate cancer detection through simple, minimally invasive blood work, helping clinicians make more informed decisions and improving patient outcomes.

“At Doctors Hospital, we are committed to providing our patients with the most advanced and effective tools for early diagnosis and better outcomes,” said David E. Pellow, Director of Ancillary and Support Services. “By incorporating Cizzle Bio’s CIZ1B and DEX-G2 biomarker blood tests into our diagnostic offerings, we are strengthening our ability to detect cancer earlier and deliver more proactive, personalized care to our community.”

Read the full press release here